The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress
<p>Lung cancer is one of the leading causes of cancer-related deaths worldwide with limited treatment options available. The anti-tumor effects of the TrxR inhibitor Butaselen (BS/BS1801) on lung cancer and its underlying mechanisms remain unknown.</p> <p>This study utilized lung c...
Збережено в:
| Автор: | Yifan Chen (446592) (author) |
|---|---|
| Інші автори: | Guangliang Qiang (296666) (author), Liang Jin (316008) (author), Yan Sun (22436) (author), Guozhou Zhang (22688355) (author), Fengling Hu (3595472) (author), Jinhui Feng (269301) (author), Feng Wei (426184) (author), Shengxin Zeng (22688358) (author), Lixiang Xue (23235) (author), Huihui Zeng (6700337) (author), Shaohua Ma (8746758) (author) |
| Опубліковано: |
2025
|
| Предмети: | |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Схожі ресурси
Схожі ресурси
-
The E3 ligase Tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation
за авторством: Feng-Juan Yan (21454759)
Опубліковано: (2025) -
Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025) -
Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025) -
Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025) -
Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)